Targeted inhibitors of signal pathways involved in CAF-mediated tumor promotion demonstrate that inhibiting deregulated Wnt, TGFβ and MAPK pathways in CAFs inhibits their protumorigenic effects [229,473]. The gene discussed is TGFB1; the disease is neoplasm.